Pharma & Healthcare
Global Mesalamine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 437702
- Pages: 94
- Figures: 91
- Views: 4
The global Mesalamine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
By Type: (Dominant Segment vs High-Margin Innovation)
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
By Application: (Core Demand Driver vs Emerging Opportunity)
Tablets
Capsules
Granule
Suppository
Enema
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., PharmaZell in Europe)
- Emerging Product Trends: Purity ≥ 97% adoption vs. Purity ≥ 98% premiumization
- Demand-Side Dynamics: Tablets growth in China vs. Capsules potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Mesalamine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Purity ≥ 98% in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Capsules in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Purity ≥ 97% dominance in Europe vs. Purity ≥ 98% demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
By Type: (Dominant Segment vs High-Margin Innovation)
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
By Application: (Core Demand Driver vs Emerging Opportunity)
Tablets
Capsules
Granule
Suppository
Enema
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., PharmaZell in Europe)
- Emerging Product Trends: Purity ≥ 97% adoption vs. Purity ≥ 98% premiumization
- Demand-Side Dynamics: Tablets growth in China vs. Capsules potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Mesalamine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Purity ≥ 98% in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Capsules in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Purity ≥ 97% dominance in Europe vs. Purity ≥ 98% demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Mesalamine Product Scope
1.2 Mesalamine by Type
1.2.1 Global Mesalamine Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Mesalamine by Application
1.3.1 Global Mesalamine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Mesalamine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Mesalamine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Mesalamine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Mesalamine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Mesalamine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Mesalamine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Mesalamine Sales Market Share by Region (2020-2025)
2.2.2 Global Mesalamine Revenue Market Share by Region (2020-2025)
2.3 Global Mesalamine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Mesalamine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Mesalamine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Mesalamine Market Size and Prospective (2020-2031)
2.4.2 Europe Mesalamine Market Size and Prospective (2020-2031)
2.4.3 China Mesalamine Market Size and Prospective (2020-2031)
2.4.4 India Mesalamine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Mesalamine Historic Market Review by Type (2020-2025)
3.1.1 Global Mesalamine Sales by Type (2020-2025)
3.1.2 Global Mesalamine Revenue by Type (2020-2025)
3.1.3 Global Mesalamine Price by Type (2020-2025)
3.2 Global Mesalamine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Mesalamine Sales Forecast by Type (2026-2031)
3.2.2 Global Mesalamine Revenue Forecast by Type (2026-2031)
3.2.3 Global Mesalamine Price Forecast by Type (2026-2031)
3.3 Different Types Mesalamine Representative Players
4 Global Market Size by Application
4.1 Global Mesalamine Historic Market Review by Application (2020-2025)
4.1.1 Global Mesalamine Sales by Application (2020-2025)
4.1.2 Global Mesalamine Revenue by Application (2020-2025)
4.1.3 Global Mesalamine Price by Application (2020-2025)
4.2 Global Mesalamine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Mesalamine Sales Forecast by Application (2026-2031)
4.2.2 Global Mesalamine Revenue Forecast by Application (2026-2031)
4.2.3 Global Mesalamine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Mesalamine Application
5 Competition Landscape by Players
5.1 Global Mesalamine Sales by Players (2020-2025)
5.2 Global Top Mesalamine Players by Revenue (2020-2025)
5.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2024)
5.4 Global Mesalamine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Mesalamine, Product Type & Application
5.7 Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Mesalamine Sales by Company
6.1.1.1 North America Mesalamine Sales by Company (2020-2025)
6.1.1.2 North America Mesalamine Revenue by Company (2020-2025)
6.1.2 North America Mesalamine Sales Breakdown by Type (2020-2025)
6.1.3 North America Mesalamine Sales Breakdown by Application (2020-2025)
6.1.4 North America Mesalamine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Mesalamine Sales by Company
6.2.1.1 Europe Mesalamine Sales by Company (2020-2025)
6.2.1.2 Europe Mesalamine Revenue by Company (2020-2025)
6.2.2 Europe Mesalamine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Mesalamine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Mesalamine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Mesalamine Sales by Company
6.3.1.1 China Mesalamine Sales by Company (2020-2025)
6.3.1.2 China Mesalamine Revenue by Company (2020-2025)
6.3.2 China Mesalamine Sales Breakdown by Type (2020-2025)
6.3.3 China Mesalamine Sales Breakdown by Application (2020-2025)
6.3.4 China Mesalamine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India Mesalamine Sales by Company
6.4.1.1 India Mesalamine Sales by Company (2020-2025)
6.4.1.2 India Mesalamine Revenue by Company (2020-2025)
6.4.2 India Mesalamine Sales Breakdown by Type (2020-2025)
6.4.3 India Mesalamine Sales Breakdown by Application (2020-2025)
6.4.4 India Mesalamine Major Customer
6.4.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 PharmaZell
7.1.1 PharmaZell Company Information
7.1.2 PharmaZell Business Overview
7.1.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 PharmaZell Mesalamine Products Offered
7.1.5 PharmaZell Recent Development
7.2 Syntese A/S
7.2.1 Syntese A/S Company Information
7.2.2 Syntese A/S Business Overview
7.2.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Syntese A/S Mesalamine Products Offered
7.2.5 Syntese A/S Recent Development
7.3 Cambrex Corporation
7.3.1 Cambrex Corporation Company Information
7.3.2 Cambrex Corporation Business Overview
7.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Cambrex Corporation Mesalamine Products Offered
7.3.5 Cambrex Corporation Recent Development
7.4 Divis Laboratories
7.4.1 Divis Laboratories Company Information
7.4.2 Divis Laboratories Business Overview
7.4.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Divis Laboratories Mesalamine Products Offered
7.4.5 Divis Laboratories Recent Development
7.5 Chemi SpA
7.5.1 Chemi SpA Company Information
7.5.2 Chemi SpA Business Overview
7.5.3 Chemi SpA Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Chemi SpA Mesalamine Products Offered
7.5.5 Chemi SpA Recent Development
7.6 Ipca Laboratories
7.6.1 Ipca Laboratories Company Information
7.6.2 Ipca Laboratories Business Overview
7.6.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Ipca Laboratories Mesalamine Products Offered
7.6.5 Ipca Laboratories Recent Development
7.7 Hangzhou Brother
7.7.1 Hangzhou Brother Company Information
7.7.2 Hangzhou Brother Business Overview
7.7.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Hangzhou Brother Mesalamine Products Offered
7.7.5 Hangzhou Brother Recent Development
7.8 Lianyungang Fengheng Biopharm
7.8.1 Lianyungang Fengheng Biopharm Company Information
7.8.2 Lianyungang Fengheng Biopharm Business Overview
7.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Lianyungang Fengheng Biopharm Mesalamine Products Offered
7.8.5 Lianyungang Fengheng Biopharm Recent Development
7.9 Lasa Loboratory
7.9.1 Lasa Loboratory Company Information
7.9.2 Lasa Loboratory Business Overview
7.9.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Lasa Loboratory Mesalamine Products Offered
7.9.5 Lasa Loboratory Recent Development
7.10 Corden Pharma Bergamo
7.10.1 Corden Pharma Bergamo Company Information
7.10.2 Corden Pharma Bergamo Business Overview
7.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Corden Pharma Bergamo Mesalamine Products Offered
7.10.5 Corden Pharma Bergamo Recent Development
7.11 Erregierre SpA
7.11.1 Erregierre SpA Company Information
7.11.2 Erregierre SpA Business Overview
7.11.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Erregierre SpA Mesalamine Products Offered
7.11.5 Erregierre SpA Recent Development
7.12 CTX Lifescience
7.12.1 CTX Lifescience Company Information
7.12.2 CTX Lifescience Business Overview
7.12.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.12.4 CTX Lifescience Mesalamine Products Offered
7.12.5 CTX Lifescience Recent Development
7.13 Ishita Active Pharma Ingredients
7.13.1 Ishita Active Pharma Ingredients Company Information
7.13.2 Ishita Active Pharma Ingredients Business Overview
7.13.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Ishita Active Pharma Ingredients Mesalamine Products Offered
7.13.5 Ishita Active Pharma Ingredients Recent Development
7.14 YC Biotech (Jiangsu)
7.14.1 YC Biotech (Jiangsu) Company Information
7.14.2 YC Biotech (Jiangsu) Business Overview
7.14.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.14.4 YC Biotech (Jiangsu) Mesalamine Products Offered
7.14.5 YC Biotech (Jiangsu) Recent Development
7.15 Xinxiang Tianfeng Fine Chemical
7.15.1 Xinxiang Tianfeng Fine Chemical Company Information
7.15.2 Xinxiang Tianfeng Fine Chemical Business Overview
7.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Xinxiang Tianfeng Fine Chemical Mesalamine Products Offered
7.15.5 Xinxiang Tianfeng Fine Chemical Recent Development
8 Mesalamine Manufacturing Cost Analysis
8.1 Mesalamine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Mesalamine
8.4 Mesalamine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Mesalamine Distributors List
9.3 Mesalamine Customers
10 Mesalamine Market Dynamics
10.1 Mesalamine Industry Trends
10.2 Mesalamine Market Drivers
10.3 Mesalamine Market Challenges
10.4 Mesalamine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Mesalamine Product Scope
1.2 Mesalamine by Type
1.2.1 Global Mesalamine Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Mesalamine by Application
1.3.1 Global Mesalamine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Mesalamine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Mesalamine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Mesalamine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Mesalamine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Mesalamine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Mesalamine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Mesalamine Sales Market Share by Region (2020-2025)
2.2.2 Global Mesalamine Revenue Market Share by Region (2020-2025)
2.3 Global Mesalamine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Mesalamine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Mesalamine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Mesalamine Market Size and Prospective (2020-2031)
2.4.2 Europe Mesalamine Market Size and Prospective (2020-2031)
2.4.3 China Mesalamine Market Size and Prospective (2020-2031)
2.4.4 India Mesalamine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Mesalamine Historic Market Review by Type (2020-2025)
3.1.1 Global Mesalamine Sales by Type (2020-2025)
3.1.2 Global Mesalamine Revenue by Type (2020-2025)
3.1.3 Global Mesalamine Price by Type (2020-2025)
3.2 Global Mesalamine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Mesalamine Sales Forecast by Type (2026-2031)
3.2.2 Global Mesalamine Revenue Forecast by Type (2026-2031)
3.2.3 Global Mesalamine Price Forecast by Type (2026-2031)
3.3 Different Types Mesalamine Representative Players
4 Global Market Size by Application
4.1 Global Mesalamine Historic Market Review by Application (2020-2025)
4.1.1 Global Mesalamine Sales by Application (2020-2025)
4.1.2 Global Mesalamine Revenue by Application (2020-2025)
4.1.3 Global Mesalamine Price by Application (2020-2025)
4.2 Global Mesalamine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Mesalamine Sales Forecast by Application (2026-2031)
4.2.2 Global Mesalamine Revenue Forecast by Application (2026-2031)
4.2.3 Global Mesalamine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Mesalamine Application
5 Competition Landscape by Players
5.1 Global Mesalamine Sales by Players (2020-2025)
5.2 Global Top Mesalamine Players by Revenue (2020-2025)
5.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2024)
5.4 Global Mesalamine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Mesalamine, Product Type & Application
5.7 Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Mesalamine Sales by Company
6.1.1.1 North America Mesalamine Sales by Company (2020-2025)
6.1.1.2 North America Mesalamine Revenue by Company (2020-2025)
6.1.2 North America Mesalamine Sales Breakdown by Type (2020-2025)
6.1.3 North America Mesalamine Sales Breakdown by Application (2020-2025)
6.1.4 North America Mesalamine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Mesalamine Sales by Company
6.2.1.1 Europe Mesalamine Sales by Company (2020-2025)
6.2.1.2 Europe Mesalamine Revenue by Company (2020-2025)
6.2.2 Europe Mesalamine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Mesalamine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Mesalamine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Mesalamine Sales by Company
6.3.1.1 China Mesalamine Sales by Company (2020-2025)
6.3.1.2 China Mesalamine Revenue by Company (2020-2025)
6.3.2 China Mesalamine Sales Breakdown by Type (2020-2025)
6.3.3 China Mesalamine Sales Breakdown by Application (2020-2025)
6.3.4 China Mesalamine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India Mesalamine Sales by Company
6.4.1.1 India Mesalamine Sales by Company (2020-2025)
6.4.1.2 India Mesalamine Revenue by Company (2020-2025)
6.4.2 India Mesalamine Sales Breakdown by Type (2020-2025)
6.4.3 India Mesalamine Sales Breakdown by Application (2020-2025)
6.4.4 India Mesalamine Major Customer
6.4.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 PharmaZell
7.1.1 PharmaZell Company Information
7.1.2 PharmaZell Business Overview
7.1.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 PharmaZell Mesalamine Products Offered
7.1.5 PharmaZell Recent Development
7.2 Syntese A/S
7.2.1 Syntese A/S Company Information
7.2.2 Syntese A/S Business Overview
7.2.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Syntese A/S Mesalamine Products Offered
7.2.5 Syntese A/S Recent Development
7.3 Cambrex Corporation
7.3.1 Cambrex Corporation Company Information
7.3.2 Cambrex Corporation Business Overview
7.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Cambrex Corporation Mesalamine Products Offered
7.3.5 Cambrex Corporation Recent Development
7.4 Divis Laboratories
7.4.1 Divis Laboratories Company Information
7.4.2 Divis Laboratories Business Overview
7.4.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Divis Laboratories Mesalamine Products Offered
7.4.5 Divis Laboratories Recent Development
7.5 Chemi SpA
7.5.1 Chemi SpA Company Information
7.5.2 Chemi SpA Business Overview
7.5.3 Chemi SpA Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Chemi SpA Mesalamine Products Offered
7.5.5 Chemi SpA Recent Development
7.6 Ipca Laboratories
7.6.1 Ipca Laboratories Company Information
7.6.2 Ipca Laboratories Business Overview
7.6.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Ipca Laboratories Mesalamine Products Offered
7.6.5 Ipca Laboratories Recent Development
7.7 Hangzhou Brother
7.7.1 Hangzhou Brother Company Information
7.7.2 Hangzhou Brother Business Overview
7.7.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Hangzhou Brother Mesalamine Products Offered
7.7.5 Hangzhou Brother Recent Development
7.8 Lianyungang Fengheng Biopharm
7.8.1 Lianyungang Fengheng Biopharm Company Information
7.8.2 Lianyungang Fengheng Biopharm Business Overview
7.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Lianyungang Fengheng Biopharm Mesalamine Products Offered
7.8.5 Lianyungang Fengheng Biopharm Recent Development
7.9 Lasa Loboratory
7.9.1 Lasa Loboratory Company Information
7.9.2 Lasa Loboratory Business Overview
7.9.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Lasa Loboratory Mesalamine Products Offered
7.9.5 Lasa Loboratory Recent Development
7.10 Corden Pharma Bergamo
7.10.1 Corden Pharma Bergamo Company Information
7.10.2 Corden Pharma Bergamo Business Overview
7.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Corden Pharma Bergamo Mesalamine Products Offered
7.10.5 Corden Pharma Bergamo Recent Development
7.11 Erregierre SpA
7.11.1 Erregierre SpA Company Information
7.11.2 Erregierre SpA Business Overview
7.11.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Erregierre SpA Mesalamine Products Offered
7.11.5 Erregierre SpA Recent Development
7.12 CTX Lifescience
7.12.1 CTX Lifescience Company Information
7.12.2 CTX Lifescience Business Overview
7.12.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.12.4 CTX Lifescience Mesalamine Products Offered
7.12.5 CTX Lifescience Recent Development
7.13 Ishita Active Pharma Ingredients
7.13.1 Ishita Active Pharma Ingredients Company Information
7.13.2 Ishita Active Pharma Ingredients Business Overview
7.13.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Ishita Active Pharma Ingredients Mesalamine Products Offered
7.13.5 Ishita Active Pharma Ingredients Recent Development
7.14 YC Biotech (Jiangsu)
7.14.1 YC Biotech (Jiangsu) Company Information
7.14.2 YC Biotech (Jiangsu) Business Overview
7.14.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.14.4 YC Biotech (Jiangsu) Mesalamine Products Offered
7.14.5 YC Biotech (Jiangsu) Recent Development
7.15 Xinxiang Tianfeng Fine Chemical
7.15.1 Xinxiang Tianfeng Fine Chemical Company Information
7.15.2 Xinxiang Tianfeng Fine Chemical Business Overview
7.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Xinxiang Tianfeng Fine Chemical Mesalamine Products Offered
7.15.5 Xinxiang Tianfeng Fine Chemical Recent Development
8 Mesalamine Manufacturing Cost Analysis
8.1 Mesalamine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Mesalamine
8.4 Mesalamine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Mesalamine Distributors List
9.3 Mesalamine Customers
10 Mesalamine Market Dynamics
10.1 Mesalamine Industry Trends
10.2 Mesalamine Market Drivers
10.3 Mesalamine Market Challenges
10.4 Mesalamine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Mesalamine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Mesalamine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Mesalamine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Mesalamine Sales (Tons) by Region (2020-2025)
Table 5. Global Mesalamine Sales Market Share by Region (2020-2025)
Table 6. Global Mesalamine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Mesalamine Revenue Share by Region (2020-2025)
Table 8. Global Mesalamine Sales (Tons) Forecast by Region (2026-2031)
Table 9. Global Mesalamine Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Mesalamine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Mesalamine Revenue Share Forecast by Region (2026-2031)
Table 12. Global Mesalamine Sales by Type (Tons) & (2020-2025)
Table 13. Global Mesalamine Sales Share by Type (2020-2025)
Table 14. Global Mesalamine Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Mesalamine Price by Type (US$/kg) & (2020-2025)
Table 16. Global Mesalamine Sales by Type (Tons) & (2026-2031)
Table 17. Global Mesalamine Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Mesalamine Price by Type (US$/kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Mesalamine Sales by Application (Tons) & (2020-2025)
Table 21. Global Mesalamine Sales Share by Application (2020-2025)
Table 22. Global Mesalamine Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Mesalamine Price by Application (US$/kg) & (2020-2025)
Table 24. Global Mesalamine Sales by Application (Tons) & (2026-2031)
Table 25. Global Mesalamine Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Mesalamine Price by Application (US$/kg) & (2026-2031)
Table 27. New Sources of Growth in Mesalamine Application
Table 28. Global Mesalamine Sales by Company (Tons) & (2020-2025)
Table 29. Global Mesalamine Sales Share by Company (2020-2025)
Table 30. Global Mesalamine Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Mesalamine Revenue Share by Company (2020-2025)
Table 32. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2024)
Table 33. Global Market Mesalamine Average Price by Company (US$/kg) & (2020-2025)
Table 34. Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Mesalamine, Product Type & Application
Table 36. Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Mesalamine Sales by Company (2020-2025) & (Tons)
Table 39. North America Mesalamine Sales Market Share by Company (2020-2025)
Table 40. North America Mesalamine Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Mesalamine Revenue Market Share by Company (2020-2025)
Table 42. North America Mesalamine Sales by Type (2020-2025) & (Tons)
Table 43. North America Mesalamine Sales Market Share by Type (2020-2025)
Table 44. North America Mesalamine Sales by Application (2020-2025) & (Tons)
Table 45. North America Mesalamine Sales Market Share by Application (2020-2025)
Table 46. Europe Mesalamine Sales by Company (2020-2025) & (Tons)
Table 47. Europe Mesalamine Sales Market Share by Company (2020-2025)
Table 48. Europe Mesalamine Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Mesalamine Revenue Market Share by Company (2020-2025)
Table 50. Europe Mesalamine Sales by Type (2020-2025) & (Tons)
Table 51. Europe Mesalamine Sales Market Share by Type (2020-2025)
Table 52. Europe Mesalamine Sales by Application (2020-2025) & (Tons)
Table 53. Europe Mesalamine Sales Market Share by Application (2020-2025)
Table 54. China Mesalamine Sales by Company (2020-2025) & (Tons)
Table 55. China Mesalamine Sales Market Share by Company (2020-2025)
Table 56. China Mesalamine Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Mesalamine Revenue Market Share by Company (2020-2025)
Table 58. China Mesalamine Sales by Type (2020-2025) & (Tons)
Table 59. China Mesalamine Sales Market Share by Type (2020-2025)
Table 60. China Mesalamine Sales by Application (2020-2025) & (Tons)
Table 61. China Mesalamine Sales Market Share by Application (2020-2025)
Table 62. India Mesalamine Sales by Company (2020-2025) & (Tons)
Table 63. India Mesalamine Sales Market Share by Company (2020-2025)
Table 64. India Mesalamine Revenue by Company (2020-2025) & (US$ Million)
Table 65. India Mesalamine Revenue Market Share by Company (2020-2025)
Table 66. India Mesalamine Sales by Type (2020-2025) & (Tons)
Table 67. India Mesalamine Sales Market Share by Type (2020-2025)
Table 68. India Mesalamine Sales by Application (2020-2025) & (Tons)
Table 69. India Mesalamine Sales Market Share by Application (2020-2025)
Table 70. PharmaZell Company Information
Table 71. PharmaZell Description and Business Overview
Table 72. PharmaZell Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 73. PharmaZell Mesalamine Product
Table 74. PharmaZell Recent Development
Table 75. Syntese A/S Company Information
Table 76. Syntese A/S Description and Business Overview
Table 77. Syntese A/S Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 78. Syntese A/S Mesalamine Product
Table 79. Syntese A/S Recent Development
Table 80. Cambrex Corporation Company Information
Table 81. Cambrex Corporation Description and Business Overview
Table 82. Cambrex Corporation Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 83. Cambrex Corporation Mesalamine Product
Table 84. Cambrex Corporation Recent Development
Table 85. Divis Laboratories Company Information
Table 86. Divis Laboratories Description and Business Overview
Table 87. Divis Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 88. Divis Laboratories Mesalamine Product
Table 89. Divis Laboratories Recent Development
Table 90. Chemi SpA Company Information
Table 91. Chemi SpA Description and Business Overview
Table 92. Chemi SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 93. Chemi SpA Mesalamine Product
Table 94. Chemi SpA Recent Development
Table 95. Ipca Laboratories Company Information
Table 96. Ipca Laboratories Description and Business Overview
Table 97. Ipca Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 98. Ipca Laboratories Mesalamine Product
Table 99. Ipca Laboratories Recent Development
Table 100. Hangzhou Brother Company Information
Table 101. Hangzhou Brother Description and Business Overview
Table 102. Hangzhou Brother Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 103. Hangzhou Brother Mesalamine Product
Table 104. Hangzhou Brother Recent Development
Table 105. Lianyungang Fengheng Biopharm Company Information
Table 106. Lianyungang Fengheng Biopharm Description and Business Overview
Table 107. Lianyungang Fengheng Biopharm Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 108. Lianyungang Fengheng Biopharm Mesalamine Product
Table 109. Lianyungang Fengheng Biopharm Recent Development
Table 110. Lasa Loboratory Company Information
Table 111. Lasa Loboratory Description and Business Overview
Table 112. Lasa Loboratory Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 113. Lasa Loboratory Mesalamine Product
Table 114. Lasa Loboratory Recent Development
Table 115. Corden Pharma Bergamo Company Information
Table 116. Corden Pharma Bergamo Description and Business Overview
Table 117. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 118. Corden Pharma Bergamo Mesalamine Product
Table 119. Corden Pharma Bergamo Recent Development
Table 120. Erregierre SpA Company Information
Table 121. Erregierre SpA Description and Business Overview
Table 122. Erregierre SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 123. Erregierre SpA Mesalamine Product
Table 124. Erregierre SpA Recent Development
Table 125. CTX Lifescience Company Information
Table 126. CTX Lifescience Description and Business Overview
Table 127. CTX Lifescience Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 128. CTX Lifescience Mesalamine Product
Table 129. CTX Lifescience Recent Development
Table 130. Ishita Active Pharma Ingredients Company Information
Table 131. Ishita Active Pharma Ingredients Description and Business Overview
Table 132. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 133. Ishita Active Pharma Ingredients Mesalamine Product
Table 134. Ishita Active Pharma Ingredients Recent Development
Table 135. YC Biotech (Jiangsu) Company Information
Table 136. YC Biotech (Jiangsu) Description and Business Overview
Table 137. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 138. YC Biotech (Jiangsu) Mesalamine Product
Table 139. YC Biotech (Jiangsu) Recent Development
Table 140. Xinxiang Tianfeng Fine Chemical Company Information
Table 141. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 142. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 143. Xinxiang Tianfeng Fine Chemical Mesalamine Product
Table 144. Xinxiang Tianfeng Fine Chemical Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Mesalamine Distributors List
Table 148. Mesalamine Customers List
Table 149. Mesalamine Market Trends
Table 150. Mesalamine Market Drivers
Table 151. Mesalamine Market Challenges
Table 152. Mesalamine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesalamine Product Picture
Figure 2. Global Mesalamine Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Mesalamine Sales Market Share by Type in 2024 & 2031
Figure 4. Purity ≥ 97% Product Picture
Figure 5. Purity ≥ 98% Product Picture
Figure 6. Purity ≥ 99% Product Picture
Figure 7. Global Mesalamine Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Mesalamine Sales Market Share by Application in 2024 & 2031
Figure 9. Tablets Examples
Figure 10. Capsules Examples
Figure 11. Granule Examples
Figure 12. Suppository Examples
Figure 13. Enema Examples
Figure 14. Others Examples
Figure 15. Global Mesalamine Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Mesalamine Sales Growth Rate (2020-2031) & (US$ Million)
Figure 17. Global Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 18. Global Mesalamine Price Trends Growth Rate (2020-2031) & (US$/kg)
Figure 19. Mesalamine Report Years Considered
Figure 20. Global Market Mesalamine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 21. Global Mesalamine Revenue Market Share by Region: 2020 VS 2024
Figure 22. North America Mesalamine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. North America Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 24. Europe Mesalamine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 26. China Mesalamine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. China Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 28. India Mesalamine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. India Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 30. Global Mesalamine Revenue Share by Type (2020-2025)
Figure 31. Global Mesalamine Sales Share by Type (2026-2031)
Figure 32. Global Mesalamine Revenue Share by Type (2026-2031)
Figure 33. Global Mesalamine Revenue Share by Application (2020-2025)
Figure 34. Global Mesalamine Revenue Growth Rate by Application in 2020 & 2024
Figure 35. Global Mesalamine Sales Share by Application (2026-2031)
Figure 36. Global Mesalamine Revenue Share by Application (2026-2031)
Figure 37. Global Mesalamine Sales Share by Company (2024)
Figure 38. Global Mesalamine Revenue Share by Company (2024)
Figure 39. Global 5 Largest Mesalamine Players Market Share by Revenue in Mesalamine: 2020 & 2024
Figure 40. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 41. Manufacturing Cost Structure of Mesalamine
Figure 42. Manufacturing Process Analysis of Mesalamine
Figure 43. Mesalamine Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Table 1. Global Mesalamine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Mesalamine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Mesalamine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Mesalamine Sales (Tons) by Region (2020-2025)
Table 5. Global Mesalamine Sales Market Share by Region (2020-2025)
Table 6. Global Mesalamine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Mesalamine Revenue Share by Region (2020-2025)
Table 8. Global Mesalamine Sales (Tons) Forecast by Region (2026-2031)
Table 9. Global Mesalamine Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Mesalamine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Mesalamine Revenue Share Forecast by Region (2026-2031)
Table 12. Global Mesalamine Sales by Type (Tons) & (2020-2025)
Table 13. Global Mesalamine Sales Share by Type (2020-2025)
Table 14. Global Mesalamine Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Mesalamine Price by Type (US$/kg) & (2020-2025)
Table 16. Global Mesalamine Sales by Type (Tons) & (2026-2031)
Table 17. Global Mesalamine Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Mesalamine Price by Type (US$/kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Mesalamine Sales by Application (Tons) & (2020-2025)
Table 21. Global Mesalamine Sales Share by Application (2020-2025)
Table 22. Global Mesalamine Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Mesalamine Price by Application (US$/kg) & (2020-2025)
Table 24. Global Mesalamine Sales by Application (Tons) & (2026-2031)
Table 25. Global Mesalamine Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Mesalamine Price by Application (US$/kg) & (2026-2031)
Table 27. New Sources of Growth in Mesalamine Application
Table 28. Global Mesalamine Sales by Company (Tons) & (2020-2025)
Table 29. Global Mesalamine Sales Share by Company (2020-2025)
Table 30. Global Mesalamine Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Mesalamine Revenue Share by Company (2020-2025)
Table 32. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2024)
Table 33. Global Market Mesalamine Average Price by Company (US$/kg) & (2020-2025)
Table 34. Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Mesalamine, Product Type & Application
Table 36. Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Mesalamine Sales by Company (2020-2025) & (Tons)
Table 39. North America Mesalamine Sales Market Share by Company (2020-2025)
Table 40. North America Mesalamine Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Mesalamine Revenue Market Share by Company (2020-2025)
Table 42. North America Mesalamine Sales by Type (2020-2025) & (Tons)
Table 43. North America Mesalamine Sales Market Share by Type (2020-2025)
Table 44. North America Mesalamine Sales by Application (2020-2025) & (Tons)
Table 45. North America Mesalamine Sales Market Share by Application (2020-2025)
Table 46. Europe Mesalamine Sales by Company (2020-2025) & (Tons)
Table 47. Europe Mesalamine Sales Market Share by Company (2020-2025)
Table 48. Europe Mesalamine Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Mesalamine Revenue Market Share by Company (2020-2025)
Table 50. Europe Mesalamine Sales by Type (2020-2025) & (Tons)
Table 51. Europe Mesalamine Sales Market Share by Type (2020-2025)
Table 52. Europe Mesalamine Sales by Application (2020-2025) & (Tons)
Table 53. Europe Mesalamine Sales Market Share by Application (2020-2025)
Table 54. China Mesalamine Sales by Company (2020-2025) & (Tons)
Table 55. China Mesalamine Sales Market Share by Company (2020-2025)
Table 56. China Mesalamine Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Mesalamine Revenue Market Share by Company (2020-2025)
Table 58. China Mesalamine Sales by Type (2020-2025) & (Tons)
Table 59. China Mesalamine Sales Market Share by Type (2020-2025)
Table 60. China Mesalamine Sales by Application (2020-2025) & (Tons)
Table 61. China Mesalamine Sales Market Share by Application (2020-2025)
Table 62. India Mesalamine Sales by Company (2020-2025) & (Tons)
Table 63. India Mesalamine Sales Market Share by Company (2020-2025)
Table 64. India Mesalamine Revenue by Company (2020-2025) & (US$ Million)
Table 65. India Mesalamine Revenue Market Share by Company (2020-2025)
Table 66. India Mesalamine Sales by Type (2020-2025) & (Tons)
Table 67. India Mesalamine Sales Market Share by Type (2020-2025)
Table 68. India Mesalamine Sales by Application (2020-2025) & (Tons)
Table 69. India Mesalamine Sales Market Share by Application (2020-2025)
Table 70. PharmaZell Company Information
Table 71. PharmaZell Description and Business Overview
Table 72. PharmaZell Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 73. PharmaZell Mesalamine Product
Table 74. PharmaZell Recent Development
Table 75. Syntese A/S Company Information
Table 76. Syntese A/S Description and Business Overview
Table 77. Syntese A/S Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 78. Syntese A/S Mesalamine Product
Table 79. Syntese A/S Recent Development
Table 80. Cambrex Corporation Company Information
Table 81. Cambrex Corporation Description and Business Overview
Table 82. Cambrex Corporation Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 83. Cambrex Corporation Mesalamine Product
Table 84. Cambrex Corporation Recent Development
Table 85. Divis Laboratories Company Information
Table 86. Divis Laboratories Description and Business Overview
Table 87. Divis Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 88. Divis Laboratories Mesalamine Product
Table 89. Divis Laboratories Recent Development
Table 90. Chemi SpA Company Information
Table 91. Chemi SpA Description and Business Overview
Table 92. Chemi SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 93. Chemi SpA Mesalamine Product
Table 94. Chemi SpA Recent Development
Table 95. Ipca Laboratories Company Information
Table 96. Ipca Laboratories Description and Business Overview
Table 97. Ipca Laboratories Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 98. Ipca Laboratories Mesalamine Product
Table 99. Ipca Laboratories Recent Development
Table 100. Hangzhou Brother Company Information
Table 101. Hangzhou Brother Description and Business Overview
Table 102. Hangzhou Brother Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 103. Hangzhou Brother Mesalamine Product
Table 104. Hangzhou Brother Recent Development
Table 105. Lianyungang Fengheng Biopharm Company Information
Table 106. Lianyungang Fengheng Biopharm Description and Business Overview
Table 107. Lianyungang Fengheng Biopharm Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 108. Lianyungang Fengheng Biopharm Mesalamine Product
Table 109. Lianyungang Fengheng Biopharm Recent Development
Table 110. Lasa Loboratory Company Information
Table 111. Lasa Loboratory Description and Business Overview
Table 112. Lasa Loboratory Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 113. Lasa Loboratory Mesalamine Product
Table 114. Lasa Loboratory Recent Development
Table 115. Corden Pharma Bergamo Company Information
Table 116. Corden Pharma Bergamo Description and Business Overview
Table 117. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 118. Corden Pharma Bergamo Mesalamine Product
Table 119. Corden Pharma Bergamo Recent Development
Table 120. Erregierre SpA Company Information
Table 121. Erregierre SpA Description and Business Overview
Table 122. Erregierre SpA Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 123. Erregierre SpA Mesalamine Product
Table 124. Erregierre SpA Recent Development
Table 125. CTX Lifescience Company Information
Table 126. CTX Lifescience Description and Business Overview
Table 127. CTX Lifescience Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 128. CTX Lifescience Mesalamine Product
Table 129. CTX Lifescience Recent Development
Table 130. Ishita Active Pharma Ingredients Company Information
Table 131. Ishita Active Pharma Ingredients Description and Business Overview
Table 132. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 133. Ishita Active Pharma Ingredients Mesalamine Product
Table 134. Ishita Active Pharma Ingredients Recent Development
Table 135. YC Biotech (Jiangsu) Company Information
Table 136. YC Biotech (Jiangsu) Description and Business Overview
Table 137. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 138. YC Biotech (Jiangsu) Mesalamine Product
Table 139. YC Biotech (Jiangsu) Recent Development
Table 140. Xinxiang Tianfeng Fine Chemical Company Information
Table 141. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 142. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 143. Xinxiang Tianfeng Fine Chemical Mesalamine Product
Table 144. Xinxiang Tianfeng Fine Chemical Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Mesalamine Distributors List
Table 148. Mesalamine Customers List
Table 149. Mesalamine Market Trends
Table 150. Mesalamine Market Drivers
Table 151. Mesalamine Market Challenges
Table 152. Mesalamine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesalamine Product Picture
Figure 2. Global Mesalamine Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Mesalamine Sales Market Share by Type in 2024 & 2031
Figure 4. Purity ≥ 97% Product Picture
Figure 5. Purity ≥ 98% Product Picture
Figure 6. Purity ≥ 99% Product Picture
Figure 7. Global Mesalamine Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Mesalamine Sales Market Share by Application in 2024 & 2031
Figure 9. Tablets Examples
Figure 10. Capsules Examples
Figure 11. Granule Examples
Figure 12. Suppository Examples
Figure 13. Enema Examples
Figure 14. Others Examples
Figure 15. Global Mesalamine Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Mesalamine Sales Growth Rate (2020-2031) & (US$ Million)
Figure 17. Global Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 18. Global Mesalamine Price Trends Growth Rate (2020-2031) & (US$/kg)
Figure 19. Mesalamine Report Years Considered
Figure 20. Global Market Mesalamine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 21. Global Mesalamine Revenue Market Share by Region: 2020 VS 2024
Figure 22. North America Mesalamine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. North America Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 24. Europe Mesalamine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 26. China Mesalamine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. China Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 28. India Mesalamine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. India Mesalamine Sales (Tons) Growth Rate (2020-2031)
Figure 30. Global Mesalamine Revenue Share by Type (2020-2025)
Figure 31. Global Mesalamine Sales Share by Type (2026-2031)
Figure 32. Global Mesalamine Revenue Share by Type (2026-2031)
Figure 33. Global Mesalamine Revenue Share by Application (2020-2025)
Figure 34. Global Mesalamine Revenue Growth Rate by Application in 2020 & 2024
Figure 35. Global Mesalamine Sales Share by Application (2026-2031)
Figure 36. Global Mesalamine Revenue Share by Application (2026-2031)
Figure 37. Global Mesalamine Sales Share by Company (2024)
Figure 38. Global Mesalamine Revenue Share by Company (2024)
Figure 39. Global 5 Largest Mesalamine Players Market Share by Revenue in Mesalamine: 2020 & 2024
Figure 40. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 41. Manufacturing Cost Structure of Mesalamine
Figure 42. Manufacturing Process Analysis of Mesalamine
Figure 43. Mesalamine Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232